Godavari Drugs Ltd manufactures and sale of Active Pharmaceutical Ingredients and their intermediatesBusiness Overview: Company is in the business of Manufacturing APIs, drug intermediaries, and fine chemicals and caters to the global Life Science Industry. It has an active Loan License and Contract Manufacturing tie-ups with multinational companies for APIs...
Godavari Drugs Limited has informed shareholders without registered email addresses about accessing the notice for its upcoming Annual General Meeting (AGM). These shareholders received letters providing weblinks and QR codes to view the AGM notice on the company and stock exchange websites. The AGM will be held on September 25,...
Godavari Drugs Limited has announced its 38th Annual General Meeting (AGM) will convene via Video Conferencing or Other Audio-Visual Means. Shareholders are invited to transact key business as detailed in the AGM notice, which has been sent electronically. The company emphasizes electronic communication for its Annual Report and notice, with...
Godavari Drugs' board has approved expanding its main business objectives to include manufacturing, marketing, and exporting nutraceuticals, dietary supplements, natural extracts, and food ingredients. This strategic move aims to diversify the company into a new growth area. The change, which is additive to current operations, requires shareholder approval via a...
Godavari Drugs Limited has submitted a Statement on Deviation or Variation in the utilization of funds for the quarter ended 30 June 2026. This statement, which was approved by the company's Board, informs investors about how company funds are being deployed compared to their initially planned objectives. This is important...
Godavari Drugs Limited has published advertisements regarding its financial results for the quarter ended June 30, 2026. These announcements appeared in Business Standard and Andhra Prabha newspapers. The company has made these unaudited quarterly results available on its official website. This ensures transparency for shareholders and the public, allowing easy...
